Skip to content
Grochi · Neutral pet information from South Korea · English edition한국어
Grochi.English edition
Labels & regulation

Where to report pet drug side effects in South Korea

Translated from the Korean edition · Editorial draft, not professionally reviewed. This page is an English translation of the Korean edition as checked on 2026-11-22. If the two differ, the Korean edition is the reference. 한국어판 (Korean edition)

Where to report pet drug side effects in South Korea
Short answer

South Korea's Pharmaceutical Affairs Act and the Rules on the Handling of Veterinary Drugs, etc. set safety-management and side-effect duties for manufacturers and importers, but no owner-facing reporting desk was confirmed in the sources opened.

Key takeaways

  • If an animal shows a problem after a medicine and there are emergency signs, a visit to an animal hospital comes before any side-effect report, and reporting after a veterinarian has checked the animal's condition is not too late.
  • The Pharmaceutical Affairs Act (약사법) requires a holder of product approval to carry out post-marketing safety management, including side-effect reporting, and states that a holder of approval for a medicine used only on animals may employ a veterinarian to carry out this work.
  • The Rules on the Handling of Veterinary Drugs, etc. (동물용 의약품등 취급규칙) require manufacturers and importers who learn of a side-effect case to take the necessary safety measures, but no article setting a route for owners to report directly was found in the texts opened.
  • No menu described as dedicated to veterinary drug side-effect reports was found on the website of the Animal and Plant Quarantine Agency (APQA), so a practical first step for an owner is to use the prescribing veterinarian, the pharmacy that sold the product, or the manufacturer or importer contact in the product instructions.
  • For human medicines, the Korea Institute of Drug Safety and Risk Management (한국의약품안전관리원) runs a separate reporting system, and both the U.S. FDA and the UK VMD publish routes for owners to report to a manufacturer or a government body directly.

Where do you report pet drug side effects? The conclusion first

To state the conclusion first: South Korea has legal provisions on the management of side effects of veterinary drugs, but the public sources opened did not confirm a dedicated desk where an owner can file a report directly. The Pharmaceutical Affairs Act (약사법) provides that, for medicines and similar items used only on animals, matters under the jurisdiction of the Minister of Health and Welfare or the Minister of Food and Drug Safety fall under the jurisdiction of the Minister of Agriculture, Food and Rural Affairs or the Minister of Oceans and Fisheries, and the Rules on the Handling of Veterinary Drugs, etc. (동물용 의약품등 취급규칙) (hereafter the Handling Rules) require manufacturers and importers to take safety measures when they learn of a side-effect case. However, no menu described as dedicated to veterinary drug side-effect reports was found on the website of the Animal and Plant Quarantine Agency (APQA) opened while writing this article.

So the practical order for an owner is as follows. First, if you are worried about the animal's condition, treatment comes before reporting. Second, tell the animal hospital or veterinary pharmacy (동물약국) that prescribed or sold the medicine about the symptoms and the product. Third, check whether the manufacturer or importer contact printed on the product container or instructions can be used. Grochi is not claiming that this order is a duty set by the system; it is arranged on the basis of the opened legal texts and the guidance of overseas public bodies, in which companies and veterinary professionals are at the center of the reporting system.

This article does not judge which medicine is safe or which symptom is caused by a medicine. Whether a reaction is due to a medicine is for a veterinarian to judge from the animal's condition, medical history and the other medicines given together, and an owner does not need to settle the cause in order to write a report. This article explains within what system side-effect information is collected and used, and what an owner can record so that it is easier to pass on to a veterinarian and a company.

Content limited to a particular medicine, such as reactions after giving a dewormer, is covered in other articles. This article covers only the reporting system that applies to veterinary drugs as a whole.

If you see a reaction, treatment comes before reporting

If, after a medicine, the animal seems to have trouble breathing, the face or area around the mouth swells, it collapses, has a seizure, vomits repeatedly, seems to lose consciousness, or has gums clearly different in color from usual, contact an animal hospital or a hospital that can provide emergency care right away and head there. In that situation, you should not spend time looking for how to file a side-effect report or sorting photos. A report can wait until the animal is stable, but treatment can become more dangerous the longer it is delayed.

The same principle applies when symptoms look mild. An owner cannot know whether a medicine is the cause, and should not decide on their own whether to keep giving or stop the medicine. For a prescribed medicine, tell the prescribing veterinarian; for a medicine bought at a veterinary pharmacy, tell the pharmacist who sold it or an animal hospital, and follow their instructions. This article does not advise stopping or continuing a medicine. That judgment belongs to a veterinarian who knows the medicine and the animal's condition.

On the way to the hospital, or after arriving, it is a good idea to bring the medicine package, any leftover medicine, and photos and videos of the symptoms so they can be shown. This information is used in the veterinarian's examination and is used as is when you report later. The U.S. FDA also advises that a report include the animal's prior health condition, the names of medicines and supplements, the veterinarian's examination findings, test results, and the food and treats the animal eats, which suggests that a report is useful only when it is backed by medical records.

In short, the order is treatment, then records, then reporting. A report leaves information in the system so that other animals are not harmed by the same medicine, but it does not make the animal that is sick now any better. While emergency signs are present, go to the hospital first instead of looking for a reporting desk.

How do Korean laws set out side-effect reporting?

The Pharmaceutical Affairs Act opened at the National Law Information Center has several articles related to side-effect reporting. Article 37-3, paragraph 1 provides that a holder of product approval must employ a physician, pharmacist or herb pharmacist and carry out post-marketing safety management such as risk management of new drugs, re-evaluation of medicines and side-effect reporting, and adds that a holder of product approval for a medicine intended for use on animals only may employ a veterinarian to carry out this work. Article 85, paragraph 1 provides that, for medicines and similar items used only on animals, matters under the jurisdiction of the Minister of Health and Welfare or the Minister of Food and Drug Safety fall under the jurisdiction of the Minister of Agriculture, Food and Rural Affairs or the Minister of Oceans and Fisheries, and that the Commissioner of the Ministry of Food and Drug Safety in the Act's articles is read as the Minister of Agriculture, Food and Rural Affairs or the Minister of Oceans and Fisheries.

Article 68-8 of the Pharmaceutical Affairs Act provides for reporting of side effects and the like. Paragraph 1 requires a manufacturer, a holder of product approval, an importer and a medicine wholesaler of medicines and similar items who learns of an adverse event suspected to have arisen from the product, such as disease, disability or death or another case set by Prime Minister's ordinance, to report it to the head of the Korea Institute of Drug Safety and Risk Management (한국의약품안전관리원) as prescribed by the Commissioner of the Ministry of Food and Drug Safety. Paragraph 2 requires a pharmacy opener and a medical institution opener who learn of a serious case of disease, disability or death set by Prime Minister's ordinance to report it in the same way. This article names companies, pharmacies and medical institutions as the persons with a reporting duty, and animal hospital openers and owners are not listed. However, from the article alone I could not confirm how the earlier Article 85, paragraph 1 applies this article to veterinary drugs, or which body actually receives reports on veterinary drugs.

The Handling Rules have more specific articles. Article 14 lists, among the matters a manufacturer must observe, taking the necessary safety measures when it obtains new data relating to the safety and efficacy of an approved or notified product or learns of information (including cases of side effects), and Article 19, paragraph 1 applies these provisions to importers mutatis mutandis. Article 26-2, paragraph 1 requires a seller of veterinary drugs and an opener of a veterinary pharmacy or animal hospital who suspects a product has a problem with safety or efficacy to stop selling or handling it immediately and to notify the manufacturer, the consignment manufacturer-seller or the importer.

In short, the law places duties on manufacturers and importers and on the sales and treatment settings, and no article stating where an owner must report was found in the texts opened. This does not mean owners cannot report; it means that the articles I confirmed do not state a reporting route for owners.

How is reported information used in South Korea?

In the legal texts opened, 3 uses can be confirmed. The first is the company's safety measures. As in Article 14 of the Handling Rules above, a manufacturer or importer that learns of a side-effect case must take the necessary safety measures. This article does not go as far as setting which measures to use, so the specific measures may differ from case to case.

The second is re-examination. Article 7-2 of the Handling Rules sets the re-examination period for some products such as new drugs, and gives 6 years from the date of product approval for products with a different active ingredient or a different target animal, among others, and 4 years for some other products. Under paragraph 5 of the same Article, a person who wants to undergo re-examination must submit, from data obtained during the re-examination period, data on safety and efficacy from post-marketing surveys in Korea, domestic and overseas safety reports on side effects and the like, safety reports from literature and academic society information, and data on sales status and overseas approval status. In other words, side-effect information collected after marketing becomes part of the re-examination data. The APQA's page on re-evaluation and re-examination also describes it as a system for reviewing again the safety and efficacy of veterinary drugs that have already been approved.

The third is recall decisions. Article 26-2, paragraph 2 of the Handling Rules divides risk into grades. It lists as grade 1 cases that cause a serious side effect from which recovery is not possible or lead to death, cases where a lethal ingredient is mixed in, and cases where a labeling error could affect life, and as grade 2 cases that cause a temporary side effect or one from which recovery is possible by veterinary means, among others. Paragraph 3 requires a recall plan to be submitted to the head of the APQA and others within 5 days of learning of the problem for grade 1, and within 15 days for grade 2 or grade 3. This does not mean that a notice from a single owner leads straight to a recall; this article sets out a company's assessment and action for a medicine suspected of being subject to recall.

How changes to approval details are made or how safety information is made public could not be confirmed specifically in the sources opened, so this article does not explain them.

What can you check at the APQA and at pharmacies and animal hospitals?

On the front page of the website of the Animal and Plant Quarantine Agency (the web address is apqa.go.kr, and the old address qia.go.kr connects to it), I confirmed, under the animal disease prevention menu, the veterinary drugs and veterinary drug evaluation menus, a link to electronic civil petitions for veterinary drugs, and, in the public participation section, a menu for reporting illegal online sales of veterinary drugs. Inside the veterinary drugs menu there were items for pharmaceutical inspection, re-evaluation and re-examination, other civil petition information, and domestic and overseas animal medicine information. However, none of these items was described as receiving reports of side effects or adverse events. I also opened the electronic civil petition site for veterinary drugs (medi.qia.go.kr connects to medi.apqa.go.kr). Under the electronic civil petition and report menu of this site there were items for visit consultation booking and safe-use guidance, and a shortcut with guidance on what to do when an adverse drug reaction occurs, but I did not see a menu described as accepting adverse reactions or a telephone number dedicated to adverse reactions. The same site also had menus for safety letter notices and notices of veterinary drugs subject to recall.

At the bottom of the re-evaluation and re-examination page, the telephone number 054-912-0543 of the Veterinary Drug Management Division of the Animal Disease Management Department and the main number 054-912-1000 were listed. I confirmed these as the general contact numbers of that department, not as a number dedicated to side-effect reports. The electronic civil petition site for veterinary drugs lists inquiry numbers by type of work, and the inquiry number for medicines (chemical preparations) there was 054-912-0543. Numbers can change, so it is safer to check the latest number on the website again before calling.

Some things can also be checked on site. Article 3-2 of the Handling Rules requires a pharmacist at a veterinary pharmacy and the managing pharmacist of a veterinary drug wholesaler, when selling certain medicines such as prescription veterinary drugs, veterinary hormone preparations, antibacterials and anesthetics, to give the animal owner medication guidance, to include in that guidance the name of the medicine, target of use, method and dose, efficacy and effects, side effects and contraindications, and this list also includes the withdrawal period. It may be given orally or in a written medication guide. However, pet veterinary drugs among the veterinary insecticides and dewormers in the same paragraph are excluded from this medication guidance. The product approval articles of these rules also include a provision requiring the side effects set at the time of approval to be stated on the container, package or accompanying document. So if you read the side-effect items when you receive a medicine, it is easier, when symptoms appear later, to ask a veterinarian or pharmacist whether the symptom is one listed in the instructions.

The prescribing veterinarian and the selling pharmacist are the professionals an owner can reach most easily. Because Article 26-2, paragraph 1 of the Handling Rules requires sellers and openers of veterinary pharmacies and animal hospitals to notify the company when a problem is suspected, passing on the symptoms and the product information accurately may let that information reach the company. However, I did not confirm that this happens in every case.

Is the human medicine side-effect desk the same as for veterinary drugs?

For human medicines, the Korea Institute of Drug Safety and Risk Management (한국의약품안전관리원) receives side-effect reports. The adverse event reporting guidance page of the Medicine Safety Portal (의약품안전나라) of the Ministry of Food and Drug Safety (MFDS) explains an adverse event as an unwanted sign, symptom or disease occurring during the use of a medicine, and states that it does not necessarily have to have a causal relationship with the medicine. The page says a report can be made through the Integrated Information System of the portal or by calling the Institute's main number 1644-6223 (or 14-3330), and the menu has an item for domestic adverse event reports by the general public. Article 68-3 of the Pharmaceutical Affairs Act provides that this Institute is established to collect, manage, analyze, evaluate and provide information on side effects and safety relating to medicines and similar items.

Can you then report a medicine given to an animal to the same place? The pages opened did not confirm that. The adverse event guidance page of the Medicine Safety Portal had no statement that animals are covered by adverse event reports, and the word animal appeared only in the part explaining animal testing before marketing. Article 85, paragraph 1 of the Pharmaceutical Affairs Act places medicines and similar items used only on animals under the jurisdiction of the Minister of Agriculture, Food and Rural Affairs, but that jurisdiction does not mean that the human medicine desk accepts veterinary drug reports. So this article does not state whether it is acceptable to phone the human medicine desk about a veterinary drug side effect, and records only what was confirmed.

A case that is easy to confuse is using a human medicine on an animal. There is a lot of evidence that giving a human medicine to a pet on one's own is dangerous, so this article does not cover how to do it. If a problem appears after one has already been given, take the name and ingredients of the medicine, the amount and the time, and go to an animal hospital right away. According to the UK VMD's guidance, problems caused in animals by human medicines are also covered by reports, but I could not confirm a desk for this case in Korea.

A person who develops a problem after exposure to a veterinary drug also needs to be considered separately. If a person has symptoms after touching or swallowing a veterinary drug, medical care for the person comes first. A reporting desk for this case also could not be confirmed in the sources opened.

How do the United States and the United Kingdom receive animal drug side-effect reports?

According to the website of the U.S. FDA Center for Veterinary Medicine (CVM), owners can also report. For a product approved or listed by the FDA, the page says to call the pharmaceutical company at the number on the product label, ask for a technical services representative and request a case number, and explains that the company must report to the FDA. It says an owner can also submit Form FDA 1932a directly. For an unapproved product (including a compounded medicine) or a medical device, it advises downloading and completing Form FDA 1932a (Veterinary Adverse Experience, Lack of Effect or Product Defect Report) and sending it to CVM1932a@fda.hhs.gov. For questions or a paper form, it gives AskCVM@fda.hhs.gov and the telephone number 1-888-FDA-VETS (1-888-332-8387). It separately says that animal vaccines are handled by the U.S. Department of Agriculture's APHIS and flea and tick products registered with the EPA by the National Pesticide Information Center.

The UK Veterinary Medicines Directorate (VMD) has adverse reactions in animals reported through an online form on gov.uk. The guidance page lists as covered adverse reactions or side effects in animals, problems caused in animals by human medicines, residues of animal medicines found in the environment or food, and reactions in people exposed to animal medicines, and says that a veterinarian or the product company can also be told. It says a paper form is obtained by contacting the VMD, that the telephone line takes calls Monday to Friday from 9:30 a.m. to 4 p.m., and that a company must share reports it receives with the VMD within 30 days. The VMD says it uses reports to check that medicines are safe and effective, and says it does not tell reporters how the report is progressing. In an announcement on April 22, 2026, the UK VMD said that on May 20, 2026 it would launch a new digital service through which veterinary professionals, suitably qualified persons (SQPs) and animal owners can report directly to the VMD, and that this service replaces the earlier discontinued reporting tool. At the time of writing, I could not confirm directly that the new service was actually running.

Compared with Korea, the difference that stands out is where the guidance is placed. The United States and the United Kingdom publish owner-facing guidance pages, forms and contact points on the websites of public bodies, but in Korea I could not find owner-facing guidance at the same level in the sources opened. This does not mean that the approach of those two countries applies to Korea as is, and what to do in Korea should be confirmed with the Korean legal texts above, the APQA, and a veterinarian or pharmacist.

What should an owner record?

Wherever the reporting desk is, the information needed is broadly similar. The U.S. FDA advises including the prior health condition, the names and doses of medicines and supplements, the veterinarian's examination findings, test results, and the food and treats the animal eats. This list is not a set of items required by law in Korea; it is an example of records that Grochi arranged on the basis of the FDA's guidance and the information needed when explaining at an animal hospital, and items such as product name and manufacturing lot number are Grochi's own additional examples that are not in the FDA guidance. You do not have to fill in every item, and even a single photo of the medicine package is a great help.

Take a photo of the medicine information before you throw the package away. Photograph the front, back and sides so that the product name, ingredient name, approval number, lot number and expiry date are visible. For a medicine received at an animal hospital, keep the medicine bag together with the prescription details. For symptoms, note the start time and the changes, and if possible keep photos or short videos. However, do not delay emergency treatment to take photos.

Information to record when a reaction occurs (Grochi's example of records, not a statutory form)
ItemWhat to writeWhy it is needed
Product name and ingredient nameThe name exactly as printed on the package, with a photoBasic information for the veterinarian and the company to confirm it is the same medicine
Approval number and lot numberThe numbers printed on the package or containerNeeded when a company looks at whether the problem lies with the same manufacturing batch
Date, time and number of usesDate and time of the first use, and time of the last useA clue to the order in which symptoms appeared in relation to use of the medicine
Animal informationSpecies, breed, age, weight, and any usual illnessInformation for a veterinarian to judge whether the situation is the same
What was given togetherOther medicines, supplements, food, treatsThe FDA also advises including what was given and eaten together
SymptomsStart time, appearance, duration, changes, photos and videosConveys changes that are hard to describe in words accurately
Treatment detailsName of the hospital, test results, treatment receivedNeeded for a report and for follow-up consultations
Contact recordWhom you told and whenAvoids having to explain the same thing repeatedly

Common misunderstandings and when to contact a professional

The first misunderstanding is the idea that a side effect already listed in the instructions does not need to be reported. The UK VMD's guidance gives reactions already stated on the packaging as an example of what can be reported. I could not confirm how this is handled in Korea, but even a symptom listed in the instructions should be told to a veterinarian and assessed.

The second misunderstanding is the idea that you can report only when it is certain that the medicine is the cause. The guidance of the Medicine Safety Portal explains that an adverse event does not necessarily have to have a causal relationship with the medicine, and the UK VMD's guidance also gives cases where the relationship to the medicine is uncertain as an example of what can be reported. Judging the cause is for a veterinarian and the authorities, not the owner. However, this is the standard for human medicines and for the United Kingdom, and I could not confirm the standard for veterinary drugs in Korea.

The third misunderstanding is the expectation that a report will bring relief for individual harm or a reply. The UK VMD says it does not tell reporters how the report is progressing, and says the VMD cannot give medical advice. How relief for individual harm or replies work for veterinary drugs in Korea could not be confirmed in the sources opened. I read the relief provisions of the Pharmaceutical Affairs Act as articles dealing with harm from side effects to people who used a medicine, and I could not confirm any basis for this system applying to harm to animals.

The fourth misunderstanding is the idea that it is enough to report to an overseas website. The FDA and VMD forms cover products and events used in their own countries, so whether it is appropriate to send a problem with a medicine used in Korea there must follow the guidance of the body concerned.

In the following situations, contact an animal hospital or emergency care right away before reporting: when the animal seems to have trouble breathing, when the face or area around the mouth swells, when it vomits repeatedly or collapses, when it has a seizure, when it seems to lose consciousness, when it has swallowed a large amount of a medicine at once, and when a person exposed to a veterinary drug has symptoms. Even if symptoms look mild, if a problem continues after a medicine, tell the prescribing veterinarian or the selling pharmacist, along with the medicine information.

Frequently asked questions

Q Who must report veterinary drug side effects?

Article 68-8, paragraph 1 of the Pharmaceutical Affairs Act, as opened, requires manufacturers, holders of product approval, importers and wholesalers of medicines and similar items to report when they learn of an adverse event, and paragraph 2 requires pharmacy and medical institution openers to report serious cases. Article 14 of the Rules on the Handling of Veterinary Drugs, etc. requires a manufacturer that learns of a side-effect case to take safety measures, and Article 19 applies this to importers mutatis mutandis. No article setting a reporting duty for owners was found.

Q Is there a desk where an owner can report directly?

No menu dedicated to veterinary drug side-effect reports was found on the APQA website. The electronic civil petition site for veterinary drugs (medi.apqa.go.kr) was also opened, but no menu described as accepting adverse reactions was seen, only a shortcut to guidance on what to do when an adverse drug reaction occurs. Tell the prescribing veterinarian, the pharmacy that sold the product, or the manufacturer or importer contact in the product instructions first, and if needed ask the APQA's Veterinary Drug Management Division, checking the latest number on the website.

Q Should I report first if a problem appears after a medicine?

No. If there are emergency signs, such as the animal seeming to have trouble breathing, collapsing or having a seizure, contact an animal hospital or emergency care right away and head there. A report can wait until the animal is stable, but treatment can become more dangerous the longer it is delayed. Bringing the medicine package and any leftover medicine to the hospital helps both the treatment and any later report.

Q Can I report a veterinary drug to the Korea Institute of Drug Safety and Risk Management, which receives human medicine side effects?

The adverse event guidance page of the Medicine Safety Portal (의약품안전나라), as opened, did not confirm that veterinary drug adverse events are covered. The Institute is described as the human medicine side-effect reporting system, so ask first whether it also accepts veterinary drug reports before calling. This article does not state that it is possible or impossible.

Q What is reported information used for?

In the Handling Rules as opened, side-effect information was connected to a manufacturer's safety measures, re-examination data and recall decisions. A person who wants to undergo re-examination must submit domestic and overseas safety reports on side effects and the like, and for a medicine suspected of being subject to recall the company must assess the risk grade and submit a recall plan. How approval details are changed and how information is made public could not be confirmed.

Q How do owners report in the United States?

According to the FDA Center for Veterinary Medicine, for an approved product you contact the pharmaceutical company at the number on the label and ask for a technical services representative and a case number. For an unapproved product or device, you complete Form FDA 1932a and send it by email, and questions go to 1-888-FDA-VETS. This method applies to U.S. products and the U.S. system and does not apply as is in Korea.

Q If I report, can I be compensated for my pet's harm?

This could not be confirmed in the sources opened. The UK VMD says it does not tell reporters how the report is progressing and does not give medical advice. I read the relief provisions of the Korean Pharmaceutical Affairs Act as dealing with harm from side effects to people who used a medicine, and I could not find a basis for them applying to animals.

Limits and scope of this guide

This article is an editorial draft that has not had specialist veterinary or pharmacist review. It is not guidance on diagnosis, prescription or treatment when an animal is ill or has a problem after a medicine, and if there are emergency signs, a visit to an animal hospital comes first. I could not confirm, in the sources opened, a desk in Korea where owners can file a veterinary drug side-effect report directly, whether the electronic civil petition site for veterinary drugs actually accepts adverse reactions (only a shortcut to guidance on what to do was confirmed), which body actually receives veterinary drug reports, how approval details are changed and how information is made public, or whether relief for harm is available. The legal texts are those as opened and may be amended afterward.

Translated from the Korean edition · Editorial draft, not professionally reviewed. The Korean edition is an explainer newly written from public sources; it is not a full translation of those sources. Veterinary expert review has not been completed. For decisions about your pet's health, talk to a veterinarian who knows your pet.

Sources and check dates

  1. Pharmaceutical Affairs Act, Articles 37-3, 68-3, 68-8 and 85 (약사법) ↗

    Used as the basis for confirming the articles on post-marketing safety management and who must report side effects, the special rule on jurisdiction over veterinary drugs, and the purpose for which the Korea Institute of Drug Safety and Risk Management is established.

  2. Rules on the Handling of Veterinary Drugs, etc., Articles 3-2, 7-2, 14, 19 and 26-2 (동물용 의약품등 취급규칙) ↗

    Used as the basis for confirming the safety measures of manufacturers and importers, re-examination data, risk grades and recall plans, and the items of medication guidance.

  3. Re-evaluation and re-examination (veterinary drugs) (재평가 및 재심사(동물용의약품)) ↗

    Used as the basis for confirming the introduction of the system for re-reviewing the safety and efficacy of approved veterinary drugs, and the contact numbers of the Veterinary Drug Management Division.

  4. Front page and veterinary drug menu of the Animal and Plant Quarantine Agency website (농림축산검역본부 누리집 첫 화면과 동물용의약품 메뉴) ↗

    Used as the basis for confirming the structure of the veterinary drugs menu, the electronic civil petition and illegal online sales reporting menus, the fact that no dedicated side-effect reporting menu was seen, and the menus and inquiry numbers by type of work on the electronic civil petition site (medi.apqa.go.kr).

  5. What is adverse event reporting? (이상사례 보고란?) ↗

    Used as the basis for confirming the definition of an adverse event for human medicines, the reporting methods, and the telephone number of the Korea Institute of Drug Safety and Risk Management.

  6. How to Report Animal Drug and Device Side Effects and Product Problems ↗

    Used as the basis for confirming contact with the manufacturer, submission of Form FDA 1932a, the contact points, and the information to include in a report.

  7. Report an animal's reaction to animal medicine ↗

    Used as the basis for confirming what can be reported, the online, paper form and telephone routes, the company's duty to share within 30 days, and the purpose for which reports are used.

  8. New animal medicine adverse event reporting service launching May 2026 ↗

    Used as the basis for confirming the statement in the April 22, 2026 announcement that from May 20 a new service would let veterinary professionals, SQPs and animal owners report directly to the VMD. Whether it is actually running could not be confirmed.

Korean edition checked · translated · each source may have a different check date. No paid partnerships.

This guide relies on 2 Korean laws or notices. Current effective dates and upcoming amendments are listed on Korean law check status. This is not legal advice.